Blood thinner for children getting a central line
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether giving a blood thinner before placing a central line (a special IV) helps prevent clots in critically ill children. It could lower the risk of problems from the line.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is in the hospital and needs a new central line for their care.
- Your child does not have a known bleeding disorder or very low platelets (under 50,000).
- Your child is not already on blood thinners for another reason.
- Your child does not have a heparin allergy or a history of a low-platelet reaction to heparin.
- The line being placed is a standard central line or PICC, not a dialysis catheter.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This study tests if using a blood test called anti-factor Xa helps doctors give the right amount of blood-thinning medicine to prevent clots in burn patients. It's for adults with moderate-to-large burns who need clot prevention while in the intensive care unit.
This study tests whether a blood thinner (LMWH) can help prevent dangerous blood clots in teens with a central line and infection or inflammation in the pediatric intensive care unit (PICU). It aims to find a safer, more personalized way to use preventive treatment.
This trial tests whether starting enoxaparin (a blood-thinner) within 24 hours after placing a specific type of central line can prevent dangerous clots. It may help reduce clot risk in people whose line is placed in the neck or thigh vein, while also tracking bleeding side effects.
This study looks at how blood clotting is activated in new central venous catheters (large IVs placed in a chest vein). It may help doctors understand and reduce clotting risks. You can join if you need a new catheter and are not on strong blood thinners.
This trial is testing a new way to give blood thinners to people who have been in a serious accident. The goal is to see if adjusting the dose based on your blood levels helps prevent dangerous blood clots.
Hear when a new Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.